May 24, 2025 a 11:43 am

IR: Fundamental Ratio Analysis - Ingersoll Rand Inc.

Ingersoll Rand Inc. stock overview

Ingersoll Rand Inc. showcases moderate performance across various financial metrics, reflecting balanced growth and management effectiveness. The stock holds a promising outlook owing to its diversified operations spanning crucial industrial sectors. Investors should consider its consistent presence across global markets while evaluating risk versus reward.

Fundamental Rating

Ingersoll Rand's overall score suggests a reliable investment with room for growth. Each category score indicates areas of strength and opportunities for improvement.
Category Score Visualization
Discounted Cash Flow (DCF) 3
Return on Equity (ROE) 3
Return on Assets (ROA) 4
Debt to Equity 5
Price to Earnings (P/E) 1
Price to Book (P/B) 2

Historical Rating

Reviewing historical scores offers insights into Ingersoll Rand's financial trajectory.
Date Overall DCF ROE ROA Debt to Equity P/E P/B
2025-05-23 3 3 3 4 5 1 2
2025-05-24 0 3 3 4 5 1 2

Analyst Price Targets

Analysts present their stock valuations with a consensus indicating potential appreciation. The targets provide a spectrum of expected stock prices.
High Low Median Consensus
105 77 93 91.67
Ingersoll Rand Inc. stock chart

Analyst Sentiment

The general sentiment towards Ingersoll Rand Inc. is positive, with most analysts recommending buying the stock.
Recommendation Type Count Visualization
Strong Buy 0
Buy 9
Hold 4
Sell 0
Strong Sell 0

Conclusion

Ingersoll Rand Inc. is positioned well within its industry, displaying solid financial metrics and retaining investor confidence through strategic operations. The stock's global market reach provides redundancy against localized economic downturns. While its consistent fundamentals are reassuring, future growth might capitalize further on innovation within its tooling and infrastructure divisions. Potential risks include market volatility and competition within its various sectors. Nonetheless, the general analyst consensus remains optimistic.